Approach to Personalizing Treatment of Triple-Negative Breast Cancer Shows Promise in Cell Lines
Michigan Medicine - University of MichiganA group of researchers at the University of Michigan Rogel Cancer Center is laying the foundations for a new, “multi-omic” approach that could help determine the drugs to which a particular triple-negative tumor will be most likely to respond based on the totality of its molecular features.